Intratumoral Injection of Allogeneic NK Cell With Chemotherapy in a Triple-negative Breast Cancer Preclinical Model
IT injection of NK cells was feasible and added anticancer efficacy to systemic chemotherapy in TNBC preclinical models. Therefore, this study supports the rationale of further clinical development of IT NK therapy with or without chemotherapy in patients with TNBC.
Authors
- Kamal Pandey (ORCID: https://orcid.org/0000-0003-2144-0577)
- I. Lee
- Nahee Park (ORCID: https://orcid.org/0000-0003-2146-6996)
- Sa Deok Hong
- Yong Wha Moon (ORCID: https://orcid.org/0000-0002-7943-974X)
- Nar Bahadur Katuwal (ORCID: https://orcid.org/0000-0002-7648-8044)
- Mithun Ghosh
- Seul‐Gi Kim (ORCID: https://orcid.org/0000-0003-1641-4059)
- Young Seok Baek
- Min Sil Kang (ORCID: https://orcid.org/0000-0003-0062-1934)
- Seung Ryeol Lee (ORCID: https://orcid.org/0000-0002-9959-3488)
- Hee Jung Ahn
- Young Bin Cho
- AH-YOUNG KOWN
Institutions
- CHA University Bundang Medical Center (KR)
- CHA University (KR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-05-27
- DOI
- https://doi.org/10.21873/anticanres.17638
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00